None (HSDT) is a publicly traded company. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma.
Analysis Summary
None reported revenue of $6.0M in the most recent fiscal year, growing at a 5-year CAGR of 55.5%.
Trailing-twelve-month margins: gross margin 95.5%, operating margin -200.5%, net margin -13.0%.
Balance sheet quality for HSDT: current ratio of 10.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.99 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 95.53% |
| Operating Margin | -200.47% |
| Net Margin | -1302.78% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 13.31 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 11.60 |
Price Performance
| 1 month | +29.21% |
| 3 months | +41.98% |
| Year-to-date | -20.42% |
| 1 year | -89.89% |
| 3 years | -99.96% |
| 5 years | -100.00% |
52-Week Range
| 52-week High | $25.50 |
| 52-week Low | $1.19 |
| Avg Volume (90d) | 307K |
Related companies: CATX · ELMD · INFU · INGN · NNOX · OM · PROF
More sections of HSDT: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks